GL1X · GenesisL1 explorer

MolNFT v1 · #173891 · protein

Structure of DDR1 receptor tyrosine kinase in complex with inhibitor SR159

7BE6 · Epithelial discoidin domain-containing receptor 1: “Structure of DDR1 receptor tyrosine kinase in complex with inhibitor SR159”. X-ray diffraction, 3 ligands (TJW, PO4, SO4), 3 pockets (best druggability 0.71). MolNFT v1 #173891 on…

PDB
7BE6
Type
protein
Length
302 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Epithelial discoidin domain-containing receptor 1
EC
2.7.10.1
UniProt
Q08345
Ligands
TJW, PO4, SO4
Pockets
3 · best druggability 0.71

Structure

x-ray diffraction · 1 distinct chain · 40% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEpithelial discoidin domain-containing receptor 1 (EC 2.7.10.1)protein30240% helix, 17% strandQ08345

Ligands and binding sites

  • TJW · 5-amino-N-(4-(((2S)-4-cyclohexyl-1-((1-(methylsulfonyl)piperidin-3-yl)amino)-1-oxobutan-2-yl)carbamoyl)benzyl)-1-phenyl-1H-pyrazole-4-carboxamide · ligand · chains A
  • PO4 · Phosphate ion · ion · chains A
  • SO4 · Sulfate ion · ion · chains A
  • EDO · 1,2-ethanediol · additive · 7 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
17160.710.7756EDO, TJW
22250.540.7726empty
3890.420.7816empty

Compared structures

  • 7BE6 · Structure of DDR1 receptor tyrosine kinase in complex with inhibitor SR159 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q08345 · AlphaFold monomer V2.0 prediction for epithelial discoidin domain- containing receptor 1… · a predicted model of the same protein · chain A against A, TM-score 0.95

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.